Literature DB >> 18187519

Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-alpha.

Kimberley Lewis1, Jackie Caldwell, Van Phan, David Prescott, Aisha Nazli, Arthur Wang, Johan D Soderhölm, Mary H Perdue, Philip M Sherman, Derek M McKay.   

Abstract

A defect in mitochondrial activity contributes to many diseases. We have shown that monolayers of the human colonic T84 epithelial cell line exposed to dinitrophenol (DNP, uncouples oxidative phosphorylation) and nonpathogenic Escherichia coli (E. coli) (strain HB101) display decreased barrier function. Here the impact of DNP on macrophage activity and the effect of TNF-alpha, DNP, and E. coli on epithelial permeability were assessed. DNP treatment of the human THP-1 macrophage cell line resulted in reduced ATP synthesis, and, although hyporesponsive to LPS, the metabolically stressed macrophages produced IL-1beta, IL-6, and TNF-alpha. Given the role of TNF-alpha in inflammatory bowel disease (IBD) and the association between increased permeability and IBD, recombinant TNF-alpha (10 ng/ml) was added to the DNP (0.1 mM) + E. coli (10(6) colony-forming units), and this resulted in a significantly greater loss of T84 epithelial barrier function than that elicited by DNP + E. coli. This increased epithelial permeability was not due to epithelial death, and the enhanced E. coli translocation was reduced by pharmacological inhibitors of NF-kappabeta signaling (pyrrolidine dithiocarbamate, NF-kappabeta essential modifier-binding peptide, BAY 11-7082, and the proteosome inhibitor, MG132). In contrast, the drop in transepithelial electrical resistance was unaffected by the inhibitors of NF-kappabeta. Thus, as an integrative model system, our findings support the induction of a positive feedback loop that can severely impair epithelial barrier function and, as such, could contribute to existing inflammation or trigger relapses in IBD. Thus metabolically stressed epithelia display increased permeability in the presence of viable nonpathogenic E. coli that is exaggerated by TNF-alpha released by activated immune cells, such as macrophages, that retain this ability even if they themselves are experiencing a degree of metabolic stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187519     DOI: 10.1152/ajpgi.00382.2007

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  19 in total

Review 1.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

Review 2.  Recent advances in small bowel diseases: Part I.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 3.  Impact of stressor exposure on the interplay between commensal microbiota and host inflammation.

Authors:  Jeffrey D Galley; Michael T Bailey
Journal:  Gut Microbes       Date:  2014-04-01

4.  Indomethacin-induced translocation of bacteria across enteric epithelia is reactive oxygen species-dependent and reduced by vitamin C.

Authors:  Ida Schoultz; Catherine M McKay; Rabea Graepel; Van C Phan; Arthur Wang; Johan Söderholm; Derek M McKay
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-14       Impact factor: 4.052

5.  The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine.

Authors:  Belén Arribas; Natividad Garrido-Mesa; Laura Perán; Desirée Camuesco; Mònica Comalada; Elvira Bailón; Mónica Olivares; Jordi Xaus; Laurens Kruidenier; Ian R Sanderson; Antonio Zarzuelo; Maria Elena Rodríguez-Cabezas; Julio Gálvez
Journal:  Eur J Nutr       Date:  2011-06-19       Impact factor: 5.614

6.  Campylobacter jejuni induces transcytosis of commensal bacteria across the intestinal epithelium through M-like cells.

Authors:  Lisa D Kalischuk; Frances Leggett; G Douglas Inglis
Journal:  Gut Pathog       Date:  2010-11-01       Impact factor: 4.181

7.  Reduced surface expression of epithelial E-cadherin evoked by interferon-gamma is Fyn kinase-dependent.

Authors:  David Smyth; Gabriella Leung; Maria Fernando; Derek M McKay
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

Review 8.  No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation.

Authors:  Steven C Gribar; Ward M Richardson; Chhinder P Sodhi; David J Hackam
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

9.  Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis.

Authors:  Arthur Wang; Åsa V Keita; Van Phan; Catherine M McKay; Ida Schoultz; Joshua Lee; Michael P Murphy; Maria Fernando; Natalie Ronaghan; Dale Balce; Robin Yates; Michael Dicay; Paul L Beck; Wallace K MacNaughton; Johan D Söderholm; Derek M McKay
Journal:  Am J Pathol       Date:  2014-07-14       Impact factor: 4.307

Review 10.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.